반응식
[CH:1]([C:3]1[CH:21]=[CH:20][C:6]([O:7][C:8]2[CH:17]=[CH:16][CH:15]=[C:14]([O:18][CH3:19])[C:9]=2[C:10]([O:12][CH3:13])=[O:11])=[CH:5][CH:4]=1)=[O:2].O[CH2:23][C:24]1[CH:29]=[CH:28][C:27]([C:30]2[S:34](=[O:36])(=[O:35])[NH:33][C:32](=[O:37])[CH:31]=2)=[CH:26][CH:25]=1.C([SiH](CC)CC)C>Cl.O1CCOCC1>[O:35]=[S:34]1(=[O:36])[C:30]([C:27]2[CH:28]=[CH:29][C:24]([CH2:23][O:2][CH2:1][C:3]3[CH:21]=[CH:20][C:6]([O:7][C:8]4[CH:17]=[CH:16][CH:15]=[C:14]([O:18][CH3:19])[C:9]=4[C:10]([O:12][CH3:13])=[O:11])=[CH:5][CH:4]=3)=[CH:25][CH:26]=2)=[CH:31][C:32](=[O:37])[NH:33]1참가 물질
반응물 3
생성물 1
시약·촉매·용매 2
실험 절차
Methyl 2-(4-formylphenoxy)-6-methoxybenzoate (0.071 g, 0.24 mmol) and 5-[4-(hydroxymethyl)phenyl]isothiazol-3(2H)-one 1,1-dioxide (0.050 g, 0.21 mmol) were dissolved in 4 M hydrogen chloride in 1,4-dioxane (2.1 m). The reaction was stirred at ambient temperature for 1.25 h. Triethylsilane (0.13 mL, 0.84 mmol) was added and stirred for 18 h. The reaction was quenched with acetone and evaporated. The product was purified on a 50 mm Luna C18 column using a 20–100% acetonitrile in water gradient with 0.05% trifluoroacetic acid at 30 mL per minute over a 30 minute period. The product was lyophilized to give a white powder (6 mg, 6%). 1H NMR (400 MHz, CDCl3): δ 7.79 (d, J=8.4 Hz, 2H), 7.53 (d, J=8.1 Hz, 2H), 7.32 (m, 2H), 6.71 (s, 1H), 6.69 (d, J=8.5 Hz, 1H), 6.49 (d, J=8.3 Hz, 1H), 4.62 (m, 2H), 4.55 (m, 2H), 3.87 (s, 3H), 3.85 (s, 3H); LCMS found for C26H23NNaO8S (M+Na)+: m/z=532.0.
후처리
- stirringstirred for 18 h
- customThe reaction was quenched with acetone
- customevaporated
- customThe product was purified on a 50 mm Luna C18 column
- customover a 30 minute
출처 및 근거
- ORD 기록
- ord-114ff7770eb54feca447758c34f78314
- 출처 데이터셋
- uspto-grants-2006_11
- 특허 번호
- US07141596B2
연결된 노트
불러오는 중…